Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
PDF VersionTARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursd
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Express News | Prestige Consumer Healthcare Inc : D.a. Davidson Raises to Buy From Neutral
DA Davidson Upgrades Prestige Consumer Healthcare to Buy From Neutral, Adjusts Price Target to $93 From $65
Prestige Consumer Healthcare (PBH) has an average rating of outperform and price targets ranging from $65 to $81, according to analysts polled by Capital IQ.
D.A. Davidson Upgrades Prestige Consumer Healthcare(PBH.US) to Buy Rating, Announces Target Price $93
D.A. Davidson analyst Linda Bolton Weiser upgrades $Prestige Consumer Healthcare(PBH.US)$ to a buy rating, and sets the target price at $93.According to TipRanks data, the analyst has a success rate o
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Business Is Trailing The Industry But Its Shares Aren't
It's not a stretch to say that Prestige Consumer Healthcare Inc.'s (NYSE:PBH) price-to-sales (or "P/S") ratio of 2.9x right now seems quite "middle-of-the-road" for companies in the Pharmaceuticals i
Prestige Consumer Healthcare (PBH) Down 0.4% Since Last Earnings Report: Can It Rebound?
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
PDF Version TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerc
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Prestige Consumer Healthcare (NYSE:PBH) has had a rough month with its share price down 7.3%. But if you pay close attention, you might gather that its strong financials could mean that the stock co
Dramamine Ditches the 'Drama on Deck' With a Summer Sweepstakes Giving Away Two Private Yacht Charters
The #1 brand in motion related nausea relief teamed up with TV personality and former chief steward Kate Chastain to share how she keeps summer travel drama-freeTARRYTOWN, N.Y., May 22, 2024 /PRNewsw
Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity
Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity
Canadian Investment Banking Group: Maintaining the Prestige Consumer (PBH.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $80.00 to $80.00.
Canadian Investment Banking Group: Maintaining the Prestige Consumer (PBH.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $80.00 to $80.00.
Canaccord Genuity Maintains Buy on Prestige Consumer, Maintains $80 Price Target
Canaccord Genuity analyst Susan Anderson maintains Prestige Consumer with a Buy and maintains $80 price target.
Prestige Consumer Healthcare: A Strong Buy Amid Solid Financials and Strategic Growth Initiatives
Prestige Consumer Hlthcr Is Maintained at Neutral by DA Davidson
Prestige Consumer Hlthcr Is Maintained at Neutral by DA Davidson
Prestige Consumer Hlthcr Price Target Maintained With a $65.00/Share by DA Davidson
Prestige Consumer Hlthcr Price Target Maintained With a $65.00/Share by DA Davidson
DA Davidson: Maintaining the Prestige Consumer (PBH.US) rating, adjusted from neutral to neutral, and adjusted the target price from $65.00 to $65.00.
DA Davidson: Maintaining the Prestige Consumer (PBH.US) rating, adjusted from neutral to neutral, and adjusted the target price from $65.00 to $65.00.
DA Davidson Maintains Neutral on Prestige Consumer, Maintains $65 Price Target
DA Davidson analyst Linda Bolton Weiser maintains Prestige Consumer (NYSE:PBH) with a Neutral and maintains $65 price target.
Prestige Consumer Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 0.12% DA Davidson $65 → $65 Maintains Neutral 06/26/2023 -7.59% DA Davidson → $60 Reiterates Ne
Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls
Prestige Consumer Healthcare Inc. PBH delivered fourth-quarter fiscal 2024 earnings per share (EPS) of $1.02, a 4.7% decline from the year-ago period’s figure. The metric also missed the Zacks Consensus Estimate by 10.5%.